Brazil Could Launch First Spot XRP ETF Following Regulatory Approval from CVM
Brazil Could Launch First Spot XRP ETF Following Regulatory Approval from CVM
$SOL: Brazil’s CVM Approves Second Solana ETF as U.S. Regulators Hesitate
Brazil’s CVM greenlights the first Solana ETF
Brazilian Securities Regulator CVM Initiates Inquiry Into Tokenization Operations
CVM Chief: Brazilian CBDC Drex to ‘Kill’ Many Cryptocurrencies
Brazil’s CVM to pioneer tokenization use cases in 2024 regulatory sandbox
12.38MUSD
Type
Common Stock
Exchange
NYSE MKT
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1508377066
CUSIP
150837409
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
September
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.85
Dividend Share
-
Dividend Yield
-
Earnings Share
-12.4
Wall Street Target Price
240.02
EPS Estimate Current Year
-12.30
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
28,558
Gross Profit TTM
-17,624,736
EBITDA
-23,937,078
Profit Margin
0.00%
Return On Assets TTM
-62.86%
Return On Equity TTM
-244.56%
Revenue Per Share TTM
0.001
Qtly Revenue Growth YOY
-62.70%
Diluted Eps TTM
-12.4
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
11797.424
Price Book MRQ
0.9329
Enterprise Value Revenue
0
Enterprise Value EBITDA
-3
494.60
2.43%450.31
1.46%585.93
1.01%258.00
0.39%179.39
0.00%151.50
-4.36%299.84
-2.58%108.54
-1.40%92.59
-0.28%78.96
-0.15%